TMSPortable TMS Van for Treatment-Resistant Depression
Left prefrontal Transcranial Magnetic Stimulation (TMS)
+ FDA cleared TMS for treating depression
Anxiety Disorders+2
+ Behavior
+ Mental Disorders
Treatment Study
Summary
Study start date: May 10, 2025
Actual date on which the first participant was enrolled.This study explores a new way to deliver a type of treatment called transcranial magnetic stimulation (TMS) to people with depression that hasn't responded to other treatments. Researchers are creating a portable TMS unit inside a van to bring the treatment to different locations in South Carolina near Charleston. This approach could make TMS more accessible to many people who can't get treated at traditional locations. The goal is to learn how well this mobile method works and if it could be used more widely, especially in places like residential care facilities or remote clinics. Participants in the study are individuals with treatment-resistant depression living near selected clinics. They will receive TMS treatment inside the van, consisting of six sessions each day over two hours, for five days, within one or two weeks. Researchers will evaluate the effectiveness of the treatment using standard depression rating scales. Additionally, they will track the costs involved in providing this mobile service to see if it could be a feasible option for other healthcare providers in the future.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 22 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Medical Univerity of South Carolina
Charleston, United StatesOpen Medical Univerity of South Carolina in Google Maps